Widaplik Tablet
Product Images NDC 24338-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Widaplik (NDC 24338-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Structure (Amlodipine Structure)

FDA Label Image

Indapamide Structure (Indapamide Structure)

FDA Label Image

Telmisartan-structure (Telmisartan Structure)

FDA Label Image

Widaplik Ld (Widaplik Ld)

Widaplik Ld (Widaplik Ld)
This text provides information about a medication called Widaplik, which is a combination tablet containing telmisartan, amlodipine, and indapamide in specific dosages. The recommended dosage instructions, storage conditions, and manufacturer details are also included. It is important to swallow the tablets whole and keep them out of reach of children, protected from moisture and light. The manufacturer is Aurity Pharmaceuticals, Inc. and the tablets are manufactured by Piramal Pharma Limited in India.*
FDA Label Image

Widaplik Sd (Widaplik Sd)

Widaplik Sd (Widaplik Sd)
This text provides detailed information about Widaplik™ tablets, which contain a combination of telmisartan, amlodipine, and indapamide in specified dosages. It includes instructions on how to take the tablets, dosage recommendations, manufacturer details, storage instructions, and precautions. It is essential to keep the tablets out of reach of children, protect them from moisture and light, store them at a specific temperature range, and only dispense them from the original container. The text also includes identifiers such as the GTIN, serial number (S/N), expiration date (EXP), and lot number.*
FDA Label Image

Widaplik Uld (Widaplik Uld)

Widaplik Uld (Widaplik Uld)
This text provides information about a medication containing 10 mg of telmisartan, 1.25 mg of amlodipine, and 0.625 mg of indapamide. It includes details on recommended dosage, storage instructions, manufacturer information, and precautions. The tablets are to be swallowed whole and should not be cut, crushed, or chewed. The package contains only 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.